Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 8 of 8 citing Kawahara: Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases.... (0.10 sec) 

Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy


Q Zhou, JK Liao - Current pharmaceutical design, 2009 - ingentaconnect.com
Abstract: Statins are 3-hydroxy-3-methyglutaryl coenzyme A (HMG-CoA) reductase
inhibitors, which are prescribed ex- tensively for cholesterol lowering in the primary and secondary
prevention of cardiovascular disease. Recent compelling evidence suggests that the ...
Cited by 15 - Related articles - All 3 versions

Anti-inflammatory drugs and statins for arterial stiffness reduction


KM Maki-Petaja, IB Wilkinson - Current Pharmaceutical Design, 2009 - ingentaconnect.com
Abstract: Arterial stiffness is a powerful predictor of cardiovascular outcome in various patient
groups as well as in gen- eral population, and can directly accelerate the atherosclerotic
process. Arterial stiffness is regulated by numerous factors. Traditionally, mean arterial ...
Cited by 3 - Related articles - All 2 versions

The role of statins for the primary and secondary prevention of coronary heart …


K Tziomalos, AI Kakafika, VG Athyros, A … - Current …, 2009 - ingentaconnect.com
Konstantinos Tziomalos 1 ,Anna I. Kakafika 2 , Vasilios G. Athyros 2 , Asterios Karagiannis 2
and ... 1 Department of Clinical Biochemistry (Vascular Prevention Clinic) and Department of
Surgery, Royal Free Hospital Campus, University College Medical School, University ...
Cited by 3 - Related articles - All 3 versions

Rho Kinase: An Important Mediator of Atherosclerosis and Vascular Disease


Q Zhou, JK Liao - Current Pharmaceutical Design, 2009 - ingentaconnect.com
Abstract: Atherosclerosis is a complex inflammatory process characterized by the cross-talk between
excessive inflammation and lipid accumulation. In the past few years, compelling evidence suggests
that statins can decrease vascular inflammation and attenuate the development of ...
Cited by 2 - Related articles - All 2 versions

Residual internal limiting membrane in epiretinal membrane surgery


K Kifuku, Y Hata, R Kohno, S Kawahara, Y … - British Journal of …, 2009 - bjo.bmj.com
Methods: Sixty-one eyes of 59 patients with ERM were enrolled. After ERM peeling, residual
ILM was visualised with Brilliant Blue G (BBG). The residual ILM pattern was divided into three
groups: (1) residual type (ILM mostly remained), (2) half type (approximately half of ILM ...
Cited by 2 - Related articles - All 3 versions

Possible contribution of hyalocytes to idiopathic epiretinal membrane formation …


R Kohno, Y Hata, S Kawahara, T Kita, R Arita, Y … - British Journal of …, 2009 - bjo.bmj.com
Methods: Ten surgically removed ERMs were fixed in 4% paraformaldehyde and analysed by
whole-mount immunohistochemistry with anti-glial fibrillar acidic protein (GFAP) and alpha
smooth-muscle actin (αSMA) antibodies. Type I collagen gel contraction assay, an ...
Cited by 1 - Related articles - All 3 versions

Residual Internal Limiting Membrane in Epiretinal


M Surgery - bjo.bmj.com
Page 1. doi: 10.1136/bjo.2008.150623 published online February 11, 2009 Br J
Ophthalmol Kaori Kifuku, yasuaki Hata, Ri-ichiro Kohno, et al. Membrane Surgery
Residual Internal Limiting Membrane in Epiretinal http://bjo.bmj ...
Related articles

Possible Contribution of Hyalocytes to Idiopathic


R Kohno, Y Hata, S Kawahara… - bjo.bmj.com
Page 1. doi: 10.1136/bjo.2008.155069 published online May 7, 2009 Br J Ophthalmol
Ri-ichiro Kohno, Yasuaki Hata, Shuhei Kawahara, et al. Contraction Epiretinal Membrane
Formation and Its Possible Contribution of Hyalocytes to Idiopathic ...
Related articles


 


Go to Google Home - About Google - About Google Scholar

©2009 Google